Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Parotid Gland”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Testing effectiveness (Phase 2)Study completedNCT00123864
What this trial is testing

Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function

Who this might be right for
Nasopharyngeal Neoplasms
Alberta Health services 25
Testing effectiveness (Phase 2)Looking for participantsNCT04870762
What this trial is testing

Customized 3D Printed Oral Stents During Head and Neck Radiotherapy

Who this might be right for
Head and Neck CarcinomaMalignant Parotid Gland NeoplasmMaxillary Sinus Carcinoma+4 more
M.D. Anderson Cancer Center 119
Early research (Phase 1)Study completedNCT00405405
What this trial is testing

Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerParotid Gland CancerThyroid Gland Cancer+2 more
Sidney Kimmel Cancer Center at Thomas Jefferson University 13
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated with Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Early research (Phase 1)Ended earlyNCT02205398
What this trial is testing

Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy

Who this might be right for
Squamous Cell Carcinoma of Head and Neck (SCCHN)Metastatic Colorectal Cancer
Novartis Pharmaceuticals 13
Large-scale testing (Phase 3)UnknownNCT00081029
What this trial is testing

Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia

Who this might be right for
Head and Neck CancerRadiation ToxicityXerostomia
Royal Marsden NHS Foundation Trust 84
Testing effectiveness (Phase 2)Ended earlyNCT00409331
What this trial is testing

Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center 3
Not applicableStudy completedNCT01731379
What this trial is testing

Optical Detection of Peripheral Nerve Bundles During Surgery

Who this might be right for
Malignant Lymphoma of Lymph Nodes of Inguinal RegionMalignant Lymphoma of Lymph Nodes of AxillaryMalignant Lymphoma of Lymph Nodes of the Cervix+3 more
Philips Healthcare 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT02628067
What this trial is testing

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

Who this might be right for
Advanced CancerAnal CarcinomaAnal Cancer+22 more
Merck Sharp & Dohme LLC 1,609
Not applicableNot Yet RecruitingNCT06421649
What this trial is testing

Investigating the Role of Adjuvant Proton Beam Therapy in Patients With Parotid Carcinoma

Who this might be right for
Parotid Cancer
The Christie NHS Foundation Trust 97